Expense Ratio: 0.35% | AUM: 5.05B | Issuer: State Street Global Advisors

XBI Daily Price Range
XBI 52-Week Price Range

XBI - Real-Time SMART Grade™

Strong Buy

Overall SMART Grade

XBI has a real-time SMART Grade of A (Strong Buy).

Learn More About SMART Grades™

XBI - Profile & Info

The investment objective of the SPDR S&P Biotech ETF is to provide investment results that correspond generally to the total return performance of the S&P Biotechnology Select Industry Index.

Issuer State Street Global Advisors
Expense Ratio 0.35%
Assets Under Management (AUM) 5.05B
Underlying Index S&P Biotechnology Select Industry Index
Asset Class Equity
ETF Category Health & Biotech ETFs
Net Asset Value (NAV) $86.12
Options? Yes
Total Holdings 128

XBI - Top Holdings

Symbol Holding Name % of Total
BIVV Bioverativ Inc. 2.85%
ARRY Array BioPharma Inc. 2.22%
JUNO Juno Therapeutics Inc. 2.09%
LOXO Loxo Oncology Inc 1.79%
ABBV AbbVie Inc. 1.73%
IMGN ImmunoGen Inc. 1.71%
BLUE bluebird bio Inc. 1.71%
ALKS Alkermes Plc 1.69%
SRPT Sarepta Therapeutics Inc. 1.64%
IMMU Immunomedics Inc. 1.63%
NBIX Neurocrine Biosciences Inc. 1.62%
FOLD Amicus Therapeutics Inc. 1.61%
AVXS AveXis Inc. 1.60%
GBT Global Blood Therapeutics Inc 1.56%
LGND Ligand Pharmaceuticals Incorporated 1.56%
VRTX Vertex Pharmaceuticals Incorporated 1.55%
FGEN FibroGen Inc. 1.55%
GILD Gilead Sciences Inc. 1.53%
RDUS Radius Health Inc 1.52%
EXEL Exelixis Inc. 1.51%
AMGN Amgen Inc. 1.47%
ESPR Esperion Therapeutics Inc. 1.47%
BMRN BioMarin Pharmaceutical Inc. 1.45%
ALXN Alexion Pharmaceuticals Inc. 1.44%
AGIO Agios Pharmaceuticals Inc. 1.43%
ACAD ACADIA Pharmaceuticals Inc. 1.41%
EDIT Editas Medicine Inc. 1.40%
SAGE SAGE Therapeutics Inc. 1.38%
ICPT Intercept Pharmaceuticals Inc. 1.35%
DVAX Dynavax Technologies Corporation 1.34%
BPMC Blueprint Medicines Corp. 1.30%
IONS Ionis Pharmaceuticals Inc. 1.29%
SGEN Seattle Genetics Inc. 1.29%
ALNY Alnylam Pharmaceuticals Inc 1.29%
MYGN Myriad Genetics Inc. 1.27%
UTHR United Therapeutics Corporation 1.27%
CELG Celgene Corporation 1.25%
CLVS Clovis Oncology Inc. 1.25%
BIIB Biogen Inc. 1.24%
INCY Incyte Corporation 1.24%
EXAS Exact Sciences Corporation 1.22%
PTLA Portola Pharmaceuticals Inc. 1.20%
REGN Regeneron Pharmaceuticals Inc. 1.18%
PTCT PTC Therapeutics Inc. 1.14%
SGMO Sangamo Therapeutics Inc. 1.13%
FLXN Flexion Therapeutics Inc. 1.13%
MDXG MiMedx Group Inc. 1.09%
TSRO TESARO Inc. 1.04%
ANAB AnaptysBio Inc. 0.99%
ONCE Spark Therapeutics Inc. 0.99%
SPPI Spectrum Pharmaceuticals Inc. 0.95%
PBYI Puma Biotechnology Inc. 0.94%
RARE Ultragenyx Pharmaceutical Inc. 0.85%
AMAG AMAG Pharmaceuticals Inc. 0.85%
HALO Halozyme Therapeutics Inc. 0.83%
ACOR Acorda Therapeutics Inc. 0.82%
INSM Insmed Incorporated 0.80%
OPK OPKO Health Inc. 0.78%
EGRX Eagle Pharmaceuticals Inc. 0.77%
TGTX TG Therapeutics Inc. 0.77%
IRWD Ironwood Pharmaceuticals Inc. Class A 0.72%
XON Intrexon Corporation 0.72%
HRTX Heron Therapeutics Inc 0.71%
ADMS Adamas Pharmaceuticals Inc. 0.71%
SGYP Synergy Pharmaceuticals Inc. 0.69%
ALDR Alder Biopharmaceuticals Inc. 0.67%
ARNA Arena Pharmaceuticals Inc. 0.65%
XLRN Acceleron Pharma Inc 0.60%
EBS Emergent BioSolutions Inc. 0.57%
RGEN Repligen Corporation 0.57%
NTLA Intellia Therapeutics Inc. 0.57%
MNTA Momenta Pharmaceuticals Inc. 0.55%
ENTA Enanta Pharmaceuticals Inc. 0.52%
VNDA Vanda Pharmaceuticals Inc. 0.51%
ABEO Abeona Therapeutics Inc. 0.50%
PRTA Prothena Corp. Plc 0.48%
KERX Keryx Biopharmaceuticals Inc. 0.46%
FPRX Five Prime Therapeutics Inc. 0.45%
AIMT Aimmune Therapeutics Inc 0.45%
EPZM Epizyme Inc. 0.45%
CARA Cara Therapeutics Inc 0.45%
AKAO Achaogen Inc. 0.44%
MRTX Mirati Therapeutics Inc. 0.44%
LJPC La Jolla Pharmaceutical Company 0.39%
NVAX Novavax Inc. 0.37%
CTMX CytomX Therapeutics Inc. 0.36%
IOVA Iovance Biotherapeutics Inc 0.35%
FMI Foundation Medicine Inc. 0.30%
CHRS Coherus BioSciences Inc. 0.28%
ZIOP ZIOPHARM Oncology Inc. 0.28%
LXRX Lexicon Pharmaceuticals Inc. 0.27%
RTRX Retrophin Inc. 0.26%
CYTK Cytokinetics Incorporated 0.26%
BCRX BioCryst Pharmaceuticals Inc. 0.25%
INO Inovio Pharmaceuticals Inc. 0.24%
ACHN Achillion Pharmaceuticals Inc. 0.24%
AKBA Akebia Therapeutics Inc. 0.24%
PGNX Progenics Pharmaceuticals Inc. 0.23%
BOLD Audentes Therapeutics Inc. 0.23%
MGNX MacroGenics Inc. 0.21%
PDLI PDL BioPharma Inc. 0.20%
GHDX Genomic Health Inc. 0.19%
XNCR Xencor Inc. 0.18%
RIGL Rigel Pharmaceuticals Inc. 0.15%
ADRO Aduro BioTech Inc. 0.14%
GERN Geron Corporation 0.10%
U.S. Dollar 0.00%

XBI - Top Stories

View All XBI News

XBI - Price/Volume Stats

Current price $84.94
Prev. close $86.10
Day low $84.22
Day high $86.14
52-week high $101.55
52-week low $78.46
Day Volume 4,272,100
Avg. volume 4,500,773
Dividend yield 0.26%

XBI - Recent Returns

1-mo -11.30%
3-mo -15.11%
6-mo -4.66%
1-year -2.04%
3-year 29.84%
5-year 108.70%
YTD 0.28%
2017 43.77%
2016 -15.45%
2015 13.58%
2014 44.97%
2013 48.39%

XBI - Stock Chart

XBI - Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...

Get Free Updates

Join over 50,000 investors who get the latest news from ETFDailyNews.com!

Most Popular Articles

From Our Partners

Page generated in 1.8333 seconds.